Occam Places Carolyn Haley as COO at F-Prime Capital
F-Prime Capital, the independent global venture vehicle of Fidelity Investments focused on the technology and life sciences sectors, has brought on Carolyn Haley as Chief Operating Officer.
Carolyn comes to F-Prime with a richly variegated history of accomplishment in the asset management industry. Most recently she served over a decade at global investor GMO as Partner and Chief Accounting Officer. Haley previously held roles of increasing responsibility at H&Q. Her career began with PwC in the global asset management practice.
Occam Global is a biotech executive search, recruiting, and leadership advisory firm with specialties across technological fields, including Biotech, TechBio, AI-ML, Cell/Gene Therapy, Diagnostics/Genomics, Medical Devices, Research Tools, Digital Health, Alternative Energy, AgTech, EdTech, Robotics as well as adjacencies within Venture Capital and Private Equity. Occam helps build biotech executive leadership teams that meet the demands of the rapidly developing, competitive, and challenging industries it serves. Occam Global recruits leading C-Suite executives and board members for the most exciting and innovative clients across the world with a specific focus on the UK, Continental Europe, the US, and Asia.